ImmunoPrecise Antibodies Ltd.
Earnings Date & Report
Last updated:
Next earnings date: 15 Sep 2025
ImmunoPrecise Antibodies Ltd.’s last earnings date was on 28 Jul 2025.
ImmunoPrecise Antibodies Ltd. stock Earnings report, Estimates & History
| 2021-03-17 | -0.14 | -0.08 |
|---|---|---|
| 2021-12-13 | -0.17 | -0.26 |
| 2022-03-16 | -0.16 | -0.16 |
| 2022-07-29 | -0.2 | -0.17 |
| 2022-09-14 | -0.17 | -0.3 |
| 2022-12-15 | -0.14 | -0.23 |
| 2023-03-16 | -0.12 | -0.14 |
| 2023-07-10 | -0.12 | -0.15 |
| 2023-09-14 | -0.17 | -0.11 |
| 2023-12-14 | -0.09 | -0.07 |
| 2024-03-14 | -0.07439 | -0.08 |
| 2024-07-29 | -0.1 | -0.52 |
| 2024-09-16 | -0.09 | -0.11 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
ImmunoPrecise Antibodies Ltd. stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 15 Sep 2025 | N/A | N/A | N/A | N/A | N/A | |
| 28 Jul 2025 | N/A | N/A | N/A | N/A | N/A | |
| 12 Mar 2025 | N/A | N/A | N/A | N/A | N/A | |
| 10 Dec 2024 | N/A | -$0.07 | N/A | 6.43M | N/A | |
| 16 Sep 2024 | Missed | -$0.09 | -$0.11 | 4.97M | 3.79M | |
| 29 Jul 2024 | Missed | -$0.1 | -$0.52 | 4.72M | 4.72M | |
| 14 Mar 2024 | Missed | -$0.07 | -$0.08 | 4.51M | 4.62M | Earnings Call Transcript |
| 14 Dec 2023 | Beat | -$0.09 | -$0.07 | 4.31M | 4.46M | Earnings Call Transcript |
| 14 Sep 2023 | Beat | -$0.17 | -$0.11 | 3.95M | 3.48M | Earnings Call Transcript |
| 10 Jul 2023 | Missed | -$0.12 | -$0.15 | 4.29M | 4.13M | |
| 16 Mar 2023 | Missed | -$0.12 | -$0.14 | 4.22M | 3.87M | Earnings Call Transcript |
| 15 Dec 2022 | Missed | -$0.14 | -$0.23 | 3.72M | 3.80M | Earnings Call Transcript |
| 14 Sep 2022 | Missed | -$0.17 | -$0.3 | 4.13M | 3.65M | Earnings Call Transcript |
| 29 Jul 2022 | Beat | -$0.2 | -$0.17 | 3.88M | 4.08M | |
| 16 Mar 2022 | Matched | -$0.16 | -$0.16 | 3.93M | 3.79M | Earnings Call Transcript |
| 13 Dec 2021 | Missed | -$0.17 | -$0.26 | 4.1M | 3.81M | Earnings Call Transcript |
| 9 Sep 2021 | N/A | N/A | -$0.13 | N/A | 3.66M | Earnings Call Transcript |
| 28 Jul 2021 | N/A | N/A | -$0.24 | N/A | 3.96M | |
| 17 Mar 2021 | Beat | -$0.14 | -$0.08 | N/A | 3.52M | |
| 31 Jan 2021 | N/A | N/A | -$0.08 | N/A | 4.51M | |
ImmunoPrecise Antibodies Ltd. Earnings report FAQs
When is ImmunoPrecise Antibodies Ltd.'s next Earnings date?
The next earnings date of ImmunoPrecise Antibodies Ltd. is on 15 Sep 2025.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.